Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MiMedx Group (MDXG)
NASDAQ:MDXG
Holding MDXG?
Track your performance easily
MDXG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.47 - $9.49
Previous Close$9.2
Volume896.37K
Average Volume (3M)740.84K
Market Cap
$1.35B
Enterprise Value$1.28B
Total Cash (Recent Filing)$88.80M
Total Debt (Recent Filing)$19.02M
Price to Earnings (P/E)15.7
Beta0.96
Next Earnings
Mar 04, 2025EPS Estimate
$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.58
Shares Outstanding146,946,213
10 Day Avg. Volume1,473,173
30 Day Avg. Volume740,838
Standard Deviation0.20
R-Squared0.26
Alpha0.00098
Financial Highlights & Ratios
Price to Book (P/B)7.37
Price to Sales (P/S)3.96
Price to Cash Flow (P/CF)17.30
P/FCF Ratio17.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.74
Enterprise Value/Gross Profit4.80
Enterprise Value/Ebitda18.42
Forecast
1Y Price Target
$12.75Price Target Upside40.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
MiMedx Group News
PremiumCompany Announcements
MiMedx Group Inc. Reports Q3 2024 Financial Results
PremiumCompany Announcements
MiMedx Group Reports 3% Sales Increase in Q3 2024
Ownership Overview
20.68% Insiders
9.91% Mutual Funds
36.70% Other Institutional Investors
22.73% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MDXG FAQ
What was MiMedx Group’s price range in the past 12 months?
MiMedx Group lowest stock price was $5.47 and its highest was $9.49 in the past 12 months.
What is MiMedx Group’s market cap?
Currently, no data Available
When is MiMedx Group’s upcoming earnings report date?
MiMedx Group’s upcoming earnings report date is Mar 04, 2025 which is in 97 days.
How were MiMedx Group’s earnings last quarter?
MiMedx Group released its earnings results on Oct 30, 2024. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.044 by $0.006.
Is MiMedx Group overvalued?
According to Wall Street analysts MiMedx Group’s price is currently Undervalued.
Does MiMedx Group pay dividends?
MiMedx Group does not currently pay dividends.
What is MiMedx Group’s EPS estimate?
MiMedx Group’s EPS estimate is $0.07.
How many shares outstanding does MiMedx Group have?
MiMedx Group has 146,946,210 shares outstanding.
What happened to MiMedx Group’s price movement after its last earnings report?
MiMedx Group reported an EPS of $0.05 in its last earnings report, beating expectations of $0.044. Following the earnings report the stock price went up 20.387%.
Which hedge fund is a major shareholder of MiMedx Group?
Among the largest hedge funds holding MiMedx Group’s share is Royce & Associates LLC. It holds MiMedx Group’s shares valued at 6M.
---
MiMedx Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.75 (40.26% Upside)
$12.75 (40.26% Upside)
Blogger Sentiment
Bullish
MDXG Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 117.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 21.1%
Last 30 Days ▲ 43.5%
Last 30 Days ▲ 43.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.53%
12-Months-Change
Fundamentals
Return on Equity
62.47%
Trailing 12-Months
Asset Growth
29.03%
Trailing 12-Months
Company Description
MiMedx Group
MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx Group was founded on July 30, 1985 and is headquartered in Marietta, GA.
---
MDXG Earnings Call
Q3 2024
0:00 / 0:00
---
MDXG Stock 12 Month Forecast
Average Price Target
$12.75
▲(40.26% Upside)
Technical Analysis
Best Analysts Covering MDXG
1 Year
1 Year Success Rate
11/13 ratings generated profit
1 Year Average Return
+56.20%
reiterated a buy rating 7 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +56.20% per trade.
---